Literature DB >> 1358195

Characterization of bovine MHC class II polymorphism using three typing methods: serology, RFLP and IEF.

C J Davies1, L Andersson, I Joosten, P Mariani, L C Gasbarre, E J Hensen.   

Abstract

Various methods, with different strengths and weaknesses, are currently used to define polymorphism of the bovine major histocompatibility complex (MHC) class II genes. A more complete characterization of bovine lymphocyte antigen (BoLA) haplotypes can be achieved by combining several of these methods. In this study BoLA class II polymorphism was characterized using three typing methods: serology, restriction fragment length polymorphism (RFLP), and isoelectric focusing (IEF). Twenty six Holstein-Friesian and 15 Angus cattle that carried an array of serologically defined BoLA haplotypes were selected for the study. The panel included 12 BoLA complex homozygotes. The three class II typing methods recognized polymorphism associated with the same or very tightly linked genes in the DQ-DR class II subregion. In total 25 BoLA-A locus (class I)--DQ-DR subregion (class II) haplotypes were defined. Three of the serological class II specificities, Dx1, Dx3, and Dx4, were associated with more than one RFLP defined DQ-DR haplotype. The other 4 class II specificities behaved as private specificities. One BoLA haplotype was found in both Holstein and Angus cattle. Two other BoLA haplotypes defined here have previously been described in other breeds. This suggests that these haplotypes exist in strong linkage disequilibrium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358195     DOI: 10.1111/j.1744-313x.1992.tb00068.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  10 in total

1.  Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.

Authors:  Job E Lopez; Guy H Palmer; Kelly A Brayton; Michael J Dark; Stephanie E Leach; Wendy C Brown
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

2.  Extensive MHC class II DRB3 diversity in African and European cattle.

Authors:  S Mikko; L Andersson
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 3.  Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

4.  CD4(+) cytotoxic T-lymphocyte activity against macrophages pulsed with bovine herpesvirus 1 polypeptides.

Authors:  C Wang; G A Splitter
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

5.  The IPD and IMGT/HLA database: allele variant databases.

Authors:  James Robinson; Jason A Halliwell; James D Hayhurst; Paul Flicek; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

6.  Genetic diversity of BoLA-DRB3 in South American Zebu cattle populations.

Authors:  Shin-Nosuke Takeshima; Claudia Corbi-Botto; Guillermo Giovambattista; Yoko Aida
Journal:  BMC Genet       Date:  2018-05-22       Impact factor: 2.797

7.  Association of BoLA DRB3 gene polymorphisms with BoHV-1 infection and zootechnical traits.

Authors:  Juan Pablo Arismendy Morales; Albeiro López-Herrera; Julián Echeverri Zuluaga
Journal:  Open Vet J       Date:  2020-09-25

8.  The major histocompatibility complex in bovines: a review.

Authors:  Jyotsna Dhingra Behl; N K Verma; Neha Tyagi; Priyanka Mishra; Rahul Behl; B K Joshi
Journal:  ISRN Vet Sci       Date:  2012-05-28

9.  IPD--the Immuno Polymorphism Database.

Authors:  James Robinson; Jason A Halliwell; Hamish McWilliam; Rodrigo Lopez; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2012-11-24       Impact factor: 16.971

10.  Characterization of bovine MHC DRB3 diversity in global cattle breeds, with a focus on cattle in Myanmar.

Authors:  Guillermo Giovambattista; Kyaw Kyaw Moe; Meripet Polat; Liushiqi Borjigin; Si Thu Hein; Hla Hla Moe; Shin-Nosuke Takeshima; Yoko Aida
Journal:  BMC Genet       Date:  2020-09-01       Impact factor: 2.797

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.